Quality | 2023.03.16
rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn about achieving a robust, scalable and high-quality DNA supply in recombinant adeno-associated viral vector (rAAV) gene therapy manufacturing. Attendees will learn about a synthetically manufactured DNA to produce double stranded linear molecules with covalently closed ends. The featured speakers will discuss the many advantages of an enzymatic DNA technology over plasmid for the manufacturing of rAAV — quality of the material, elimination of bacterial sequences, amplification of difficult sequences including ITRs, lower amounts of DNA required for transfection and a scalable process to meet the DNA needs of any AAV manufacturing program. Attendees will learn about the use of this enzymatic DNA technology in Phase I/II.
(PRWeb March 16, 2023)
Read the full story at https://www.prweb.com/releases/raav_manufacturing_enzymatic_dna_for_achieving_a_robust_high_quality_dna_supply_upcoming_webinar_hosted_by_xtalks/prweb19227738.htm
For more information, please visit
https://www.prweb.com/releases/raav_manu[...]ed_by_xtalks/prweb19227738.htm
